Viewing Study NCT01080066


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-29 @ 9:48 AM
Study NCT ID: NCT01080066
Status: COMPLETED
Last Update Posted: 2014-07-08
First Post: 2010-02-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module